Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Nephrolyx logo — Kidney function measurement with unmatched accuracy (True GF...

Nephrolyx

Kidney function measurement with unmatched accuracy (True GFR)

Founded 2021 Germany Berlin, Germany 11 employees Biopharma

General Information

Company Name Nephrolyx
Founded Year 2021
Location Germany Berlin, Germany +1
Employees 11
Industries Biopharma
Social

Get notified when Nephrolyx moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nephrolyx

Nephrolyx is a biopharma startup founded in 2021, offering a precise and rapid measurement of kidney function through its In-Vitro Diagnostic Test and digital platform. The company's product, Nephrolyx IVDx, utilizes Ultra-High-Performance-Liquid Chromatography using Ultra-Violet light to determine serum iohexol concentration and calculate the glomerular filtration rate (GFR) with unmatched accuracy. This technology has the potential to significantly improve treatment success for kidney patients. Nephrolyx's innovative solution has the ability to benefit various medical fields including nephrology, oncology, transplantation, and ICU patients by allowing physicians to detect renal diseases and tailor optimal treatment plans with unprecedented precision. The company's technology is not only groundbreaking in terms of accuracy but also cost-effective, potentially enhancing the overall performance of the healthcare system. While Nephrolyx has not disclosed its last investment or investors, its pioneering approach to kidney function measurement presents an attractive opportunity for venture capital firms seeking to invest in cutting-edge biopharma solutions.

Taxonomy: In-Vitro Diagnostics, Kidney Function Assessment, Medical Technology, Healthcare Innovation, Nephrology Diagnostics, GFR Measurement, Clinical Testing Solutions, Rapid Diagnostics, HealthTech, Iohexol Measurement, Precision Medicine, Renal Disease Management, Acute Kidney Injury, Healthcare Diagnostics, Laboratory Solutions

No funding data available for Nephrolyx yet.

Get notified when Nephrolyx raises funding

Nephrolyx Alternatives & Competitors

Nephrolyx vs
Carenostics
Carenostics United States

Addressing the underdiagnosis, undertreatment, and health inequities of chronic disease using AI and...

Seed
13 employees
AI, Biotechnology
Nephrolyx vs
IceCure Medical
IceCure Medical Israel

The Choice of Cryoablation

Post Ipo Equity
70 employees
Biotechnology, Health Care
Nephrolyx vs
Day Zero Diagnostics, Inc
Day Zero Diagnostics, Inc United States

The future of infectious disease diagnostics starts at Day Zero.

Unknown
64 employees
Biotechnology, Health Care

FAQ About Nephrolyx

Kidney function measurement with unmatched accuracy (True GFR)
Nephrolyx was founded in 2021.
Nephrolyx is headquartered in Berlin, Germany.
Nephrolyx operates in the following industries: Biopharma.
Nephrolyx has approximately 11 employees.
Top alternatives and competitors to Nephrolyx include Carenostics, IceCure Medical, Day Zero Diagnostics, Inc, Humedics GmbH, J Mitra & Co Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nephrolyx and Carenostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nephrolyx and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy